Enasidenib for patients with relapsed acute myeloid leukemia and the IDH2 mutation
DiNardo, C.
Clinical Advances in Hematology and Oncology H&o 16(4): 247-249
2018
ISSN/ISBN: 1543-0790 PMID: 29742078 Document Number: 697214
Document emailed within 1 workday
Related Documents
Tang, J.L.; Tien, H.F.; Lin, M.T.; Chen, P.J.; Chen, Y.C. 1998: Frequent p53 mutation in relapsed acute lymphoblastic leukemia with cytogenetic instability: a longitudinal analysis Anticancer Research 18(2b): 1273-1278Gritsaev, S.V.; Martynkevich, I.S.; Chubukina, Z.V.; Petrova, E.V.; Kostroma, I.I.; Ivanova, M.P.; Martynenko, L.S.; Potikhonova, N.A.; Bubnova, L.N.; Abdulkadyrov, K.M. 2014: The specific features of the immunophenotype of blast cells in patients with de novo normal karyotype acute myeloid leukemia and FLT3-ITD mutation Terapevticheskii Arkhiv 86(3): 71-77
Bassan, R.; Lerede, T.; Buelli, M.; Borleri, G.; Bellavita, P.; Rambaldi, A.; Barbui, T. 1998: A new combination of carboplatin, high-dose cytarabine and cross-over mitoxantrone or idarubicin for refractory and relapsed acute myeloid leukemia Haematologica 83(5): 422-427
Schoch, C.; Schnittger, S.; Kern, W.; Dugas, M.; Hiddemann, W.; Haferlach, T. 2003: Acute myeloid leukemia with recurring chromosome abnormalities as defined by the WHO-classification: incidence of subgroups, additional genetic abnormalities, FAB subtypes and age distribution in an unselected series of 1,897 patients with acute myeloid leukemia Haematologica 88(3): 351-352
Cannistra, S.A.; DiCarlo, J.; Groshek, P.; Kanakura, Y.; Berg, D.; Mayer, R.J.; Griffin, J.D. 1991: Simultaneous administration of granulocyte-macrophage colony-stimulating factor and cytosine arabinoside for the treatment of relapsed acute myeloid leukemia Leukemia 5(3): 230-238
Martino, R.; Guardia, R.; Altés, A.; Sureda, A.; Brunet, S.; Sierra, J. 1999: Time sequential chemotherapy for primary refractory or relapsed adult acute myeloid leukemia: results of the phase II Gemia protocol Haematologica 84(3): 226-230
Biukhner, T.; Khiddeman, V.; Mashmeĭer, G.; Liudvig, V.; Lëffler, K.; Novrusian, M.; Aul, S.; Kheĭneke, A. 1991: How to improve results of chemotherapy of acute myeloid leukemia in adults: research of the cooperative group for studying acute myeloid leukemia in West Germany Gematologiia i Transfuziologiia 36(9): 38-40
Radojkovic, M.; Tosic, N.; Colovic, N.; Ristic, S.; Pavlovic, S.; Colovic, M. 2012: Reversal of FLT3 mutational status and sustained expression of NPM1 mutation in paired presentation, and relapse samples in a patient with acute myeloid leukemia Annals of Clinical and Laboratory Science 42(2): 186-190
Weiss, M.A. 1997: Treatment of adult patients with relapsed or refractory acute lymphoblastic leukemia (ALL) Leukemia 11(Suppl): S28-S30
Cannistra, S.A.; Groshek, P.; Griffin, J.D. 1989: Granulocyte-macrophage colony-stimulating factor enhances the cytotoxic effects of cytosine arabinoside in acute myeloblastic leukemia and in the myeloid blast crisis phase of chronic myeloid leukemia Leukemia 3(5): 328-334
Bee, P.C.; Gan, G.G.; Sangkar, V.J.; Haris, A.R. 2008: Nephrotic syndrome in a patient with relapsed of chronic myeloid leukemia after peripheral blood stem cell transplantation Medical Journal of Malaysia 63(1): 71-72
Govedarovic, N.; Marjanovic, G. 2011: Frequency and prognostic impact of FLT3/ITD mutation in patients with acute myeloid leukaemia Journal of BUON: Official Journal of the Balkan Union of Oncology 16(1): 108-111
Miyawaki, S.; Mizoguchi, H.; Tomonaga, M.; Kanamaru, A.; Tsukagoshi, S.; Nakamura, T.; Ohashi, Y.; Yoshida, S.; Ohno, R. 1998: A phase Ii study with high-dose cytarabine (NS-075) in adult patients with relapsed and refractory acute leukemia Gan to Kagaku Ryoho. Cancer and ChemoTherapy 25(14): 2229-2242
Schiffer, C.A.; Davis, R.B.; Mayer, R.J.; Peterson, B.A.; Lee, E.J. 1987: Combination chemotherapy with diaziquone and amsacrine in relapsed and refractory acute nonlymphocytic leukemia: a Cancer and Leukemia Group B Study Cancer Treatment Reports 71(9): 879-880
Misset, J.L.; Venuat, A.M.; Nevarez, L.; Mathé, G. 1977: Does blastic crisis as revealed in chronic myeloid leukemia simulate either acute primary leukemia or acute primary leukemia with Philadelphia chromosome? La Nouvelle Presse Medicale 6(27): 2409-2413
Greiner, J.; Döhner, H.; Schmitt, M. 2006: Cancer vaccines for patients with acute myeloid leukemia--definition of leukemia-associated antigens and current clinical protocols targeting these antigens Haematologica 91(12): 1653-1661
Kuse, R. 2000: The therapy of acute myeloid leukemia in patients of advanced age Deutsche Medizinische Wochenschrift 125(9): 272
Schumacher, A. 1994: Quality of life in patients with acute myeloid leukemia Medizinische Klinik 89(8): 410-415
Bellido, M.; Martino, R.; Aventín, A.; Carnicer, M.J.; Rubiol, E.; López, O.; Sierra, J.; Nomdedéu, J.F. 2000: Leukemic relapse as T-acute lymphoblastic leukemia in a patient with acute myeloid leukemia and a minor T-cell clone at diagnosis Haematologica 85(10): 1083-1086
Lemez, P.; Maresová, J. 1996: Protective effects of cardioxane against anthracycline-induced cardiotoxicity in relapsed acute myeloid leukemias Neoplasma 43(6): 417-419